Oxis Turbuhaler (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate, the active ingredient in Oxis Turbuhaler, is a long‑acting β‑adrenergic agonist presented as a dry‑powder inhalation device for inhalation use. It provides bronchodilation in patients with asthma and chronic obstructive pulmonary disease (COPD). GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Formoterol fumarate dihydrate is a bronchodilator that acts on the smooth‑muscle tone of the airways. It is indicated for: - Asthma: improves control of symptoms and reduces the frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): maintains airway patency and eases breathing during stable disease. - Exercise‑induced bronchoconstriction: prevents narrowing of the airways triggered by physical activity. - Seasonal allergic rhinitis: provides relief of nasal congestion when combined with an intranasal steroid. - Chronic bronchitis: helps to alleviate persistent cough and sputum production.

Formoterol may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Throat irritation: mild discomfort or scratch‑like sensation in the throat. - Cough: transient coughing immediately after inhalation. - Headache: mild to moderate headache. - Tremor: fine muscle tremor, often of the hands. - Palpitations: sensation of rapid or irregular heartbeat. - Dry mouth: reduced salivation leading to a dry feeling.

Serious or Rare Side Effects: - Paradoxical bronchospasm: sudden worsening of breathing difficulty. - Cardiovascular events: arrhythmia, angina, or myocardial infarction. - Hypokalemia: low blood potassium levels, potentially causing muscle weakness. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Hyperglycaemia: elevated blood glucose, particularly in diabetic patients. - Pulmonary hypertension: increased pressure in lung arteries.

When using Oxis Turbuhaler, patients and healthcare providers should consider several safety measures.

- Assess respiratory status: evaluate baseline lung function before initiating therapy. - Monitor for overuse: avoid exceeding prescribed inhalations to reduce risk of systemic effects. - Review cardiovascular history: patients with arrhythmias or coronary disease need careful observation. - Caution in pregnancy: discuss potential risks and benefits with a healthcare professional. - Avoid use in uncontrolled asthma: ensure underlying inflammation is treated with an appropriate controller. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Formoterol may interact with several medication classes, altering its safety profile.

Major Interactions (Avoid): - Non‑selective β‑blockers: may blunt bronchodilator response and precipitate bronchospasm. - Monoamine oxidase inhibitors (MAOIs): increase risk of cardiovascular side effects. - Diuretics (especially loop diuretics): may exacerbate hypokalemia.

Moderate Interactions (Monitor Closely): - Theophylline: additive stimulant‑like effects on the heart. - Anticholinergic bronchodilators: may increase risk of tachycardia. - Certain antidepressants (e.g., SSRIs): potential for heightened tremor or palpitations.